Angelman syndrome (AS) is a severe neurological disorder characterized by mental retardation, motor dysfunction and epilepsy. We show that the molecular and cellular deficits of an AS mouse model can be rescued by introducing an additional mutation at the inhibitory phosphorylation site of aCaMKII. Moreover, these double mutants no longer show the behavioral deficits seen in AS mice, suggesting that these deficits are the direct result of increased inhibitory phosphorylation of aCaMKII.
Angelman syndrome (AS) is a severe neurological disorder characterized by mental retardation, motor dysfunction and epilepsy. We show that the molecular and cellular deficits of an AS mouse model can be rescued by introducing an additional mutation at the inhibitory phosphorylation site of aCaMKII. Moreover, these double mutants no longer show the behavioral deficits seen in AS mice, suggesting that these deficits are the direct result of increased inhibitory phosphorylation of aCaMKII.
Angelman syndrome is caused by loss of function of imprinted genes on human chromosome 15q11-13 or by mutations in the UBE3A gene, which resides in this region [1] [2] [3] [4] . Imprinting of this gene results in exclusive expression of the maternal allele in hippocampal neurons and cerebellar Purkinje cells 5 . The UBE3A gene encodes the ubiquitin protein ligase E3A, also known as E6-AP, but its role remains elusive. Heterozygous mice with a maternally inherited Ube3a mutation (here called 'AS mice') show seizures and motor and cognitive abnormalities similar to the symptoms of AS individuals 6 . Biochemical analysis of these mice indicates that calcium/calmodulin-dependent kinase type 2 (CaMKII) activity is reduced and that phosphorylation of the inhibitory Thr305 and Thr306 site is increased 7 . Because increased inhibitory phosphorylation of CaMKII has a severe impact on neuronal function [8] [9] [10] , we investigated whether the increased phosphorylation is directly responsible for the major deficits seen in AS. Female AS mice were crossed with heterozygous males that carried the targeted aCaMKII-T305V/T306A mutation, which prevents inhibitory phosphorylation of aCaMKII (designated as CaMKII-305/6 +/-mice; Supplementary Methods online). This resulted in offspring with four genotypes: wild-type mice, AS mutants, aCaMKII-305/6 +/-mutants and AS/CaMKII-305/6 +/-double mutants. As reported previously 7 , western blot analysis of hippocampal lysates showed a significant increase of Thr305 phosphorylation in AS mice (130%; P o 0.05 Fisher's protected least-significant difference, PLSD). In contrast, inhibitory phosphorylation was significantly reduced in CaMKII-305/ 6 +/-mutants (40%, P o 0.001) and in AS/CaMKII-305/6 +/-double mutants ( Fig. 1a and Supplementary Fig. 1 online) . Moreover, the decreased kinase activity of the AS mutants was restored to near wildtype levels in the AS/CaMKII-305/6 +/-double mutants (Fig. 1b) . Thus, these mutants are suitable for determining the extent to which increased inhibitory phosphorylation of CaMKII underlies the neurological phenotype of AS mice.
All the mutants appeared healthy, but adult (42 months) AS mice showed a small (20%) but significant increase in body weight (P o 0.005 Fisher's PLSD; Supplementary Fig. 2 online). Although obesity is not a characteristic feature of the disease, it occurs in 15% of AS children 11 and in the majority of AS children carrying the Ube3a mutation 12 . Moreover, obesity is a common feature of children with a previously unrecognized form of AS 13 . Increased body weight was absent in AS/CaMKII-305/6 +/-double mutants (P 4 0.3). As aCaM-KII expression is restricted to neurons, these results suggest that the increased body weight of AS mice has a neurological basis and is caused by increased aCaMKII Thr 305/306 phosphorylation. Epilepsy is a common feature of AS 11, 14 . As epilepsy is absent in some AS individuals and is background dependent in AS mice 8 , several genes seem to be involved in the development of this phenotype. Nevertheless, as reduced aCaMKII activity can result in epilepsy 8 , the increased CaMKII inhibitory phosphorylation could potentially contribute to the increased seizure propensity of AS mice. Using audiogenic stimulation, we observed seizures in 50% of the AS mice, whereas no seizures were observed in wild-type mice or CaMKII-305/6 +/-mutants. Notably, there was a 75% reduction of seizure propensity in AS/CaMKII-305/6 +/-double mutants as compared with the AS mutants (P o 0.05 Pearson's test, Fig. 1c ). This suggests that the increased inhibitory phosphorylation of CaMKII strongly contributes to the increased seizure susceptibility of the AS mutants.
Motor coordination deficits are common in all AS individuals and mice 6, 14 . The UBE3A gene is imprinted in cerebellar Purkinje cells 5 , and we have shown that aCaMKII is essential for cerebellar motor learning and Purkinje cell plasticity 15 . Therefore, these deficits could well be caused by dysregulation of cerebellar CaMKII. Motor performance of the mutants was assessed using an accelerating rotarod. There was a significant difference between genotypes (F 3,31 ¼ 6.9, P o 0.005 repeated measures ANOVA): AS mice stayed on the rotarod for significantly less time than their wild-type littermates (P o 0.0001 Fisher's PLSD; Fig. 1d ). In contrast, CaMKII-305/6 +/-mutants performed better than wild-type mice (P o 0.005), whereas AS/CaMKII-305/6 +/-mice performed normal (wild type versus AS/CaMKII-305/ 6 +/-, P ¼ 0.5). These results suggest that regulation of inhibitory phosphorylation of CaMKII is critical for motor coordination performance and that the increased phosphorylation directly underlies the motor performance deficits of AS mice.
The UBE3A gene is also imprinted in the hippocampus 5 . The important function of aCaMKII in hippocampus-dependent learning 8 makes it likely that the increased inhibitory phosphorylation of aCaMKII underlies the cognitive deficits in AS individuals and mice 6 . Hippocampus-dependent learning was first assessed using the Morris water maze task. A probe trial given after 6 d of training showed a significant difference between genotypes when the number of target platform crossings was compared between mutants (F 3,66 ¼ 3.7, P o 0.05 ANOVA). Indeed, whereas wild type and CaMKII-305/6 +/-mutants showed significantly more crossings of the target platform position as compared with the other positions, AS mice did not (wild type, P o 0.0001; CaMKII-305/6 +/-, P o 0.0001; AS, P ¼ 0.16, paired t-test between target and average of other positions; Fig. 2a,b) . The learning deficit of AS mutants was not due to impaired motor performance or decreased motivation to escape, as all mutants showed similar escape latencies in the hidden platform task (F 3,31 ¼ 0.8, P ¼ 0.5 repeated measures ANOVA, Fig. 2c ) as well as in the visible platform task ( Supplementary Fig. 3 online) . Moreover, the swim speed of AS mice was similar to that of wild-type mice, and the spatial learning deficits were overcome by additional training (Supplementary Fig. 3) . Notably, the spatial learning deficits of AS mice at day 6 were again completely rescued by the CaMKII-305/6 +/-mutation, as the AS/CaMKII-305/6 +/-double mutants showed a highly selective search strategy (target crossing versus average of other positions, P o 0.0001, paired t-test).
Hippocampus-dependent learning was also assessed using contextual fear conditioning. Context-dependent memory was tested 24 h or 7 d following training (Fig. 2d) . A significant difference between genotypes was observed at both time points, with AS mice freezing significantly less than any other group (24 h: mutation (wild type versus AS/CaMKII-305/6 +/-, 24 h: P ¼ 0.6; 7 days: P ¼ 0.4 Fisher's PLSD). Because cued conditioning was normal in the AS mice ( Supplementary Fig. 4 online) , we conclude that AS mice have a hippocampal learning deficit and that the mutant phenotype can be rescued by decreasing aCaMKII inhibitory phosphorylation.
Inhibitory phosphorylation of aCaMKII is important in setting the threshold for the induction of long-term potentiation (LTP); homozygous CaMKII-305/6 mice show increased LTP at subthreshold stimulation and normal LTP when a strong stimulation protocol is applied 9 . In contrast, AS mice show a striking LTP deficit, which is rescued by a strong stimulation protocol 6, 7 . To directly test whether the LTP deficit of AS mice is due to excessive Thr 305/306 phosphorylation, we measured LTP in hippocampal slices of the mutants. Consistent with previous findings, AS mice showed a severe LTP deficit compared with wild-type mice (F 3,87 ¼ 0.3, P o 0.0001 ANOVA, all P o 0.001 Fishers PLSD; Fig. 2e) . LTP was normal in the CaMKII-305/6 +/-mice (P ¼ 0.5 Fishers PLSD), as well as in the AS/CaMKII-305/6 +/-double mutants (P ¼ 0.4 Fishers PLSD), suggesting that the plasticity deficits of AS mice are the result of increased inhibitory phosphorylation of CaMKII.
Although further research is needed to link E6-AP to CaMKII inhibitory phosphorylation, here we report a functional connection between CaMKII and a human learning and memory disorder. This study provides insight into the molecular basis of the motor, seizure and cognitive facets observed in Angelman syndrome.
